Bioceres Crop Solutions Corp Financials
This page shows Bioceres Crop Solutions Corp (BIOX) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 9 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores
Bioceres Crop Solutions Corp's revenue declined 27.9% year-over-year, from $464.8M to $335.1M. This contraction results in a growth score of 0/100.
Bioceres Crop Solutions Corp carries a low D/E ratio of 0.03, meaning only $0.03 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 100/100, indicating a strong balance sheet with room for future borrowing.
Bioceres Crop Solutions Corp's current ratio of 0.91 means current assets barely cover short-term liabilities. This tight liquidity results in a low score of 13/100, which could limit financial flexibility.
Bioceres Crop Solutions Corp has a free cash flow margin of 13.2%, earning a moderate score of 58/100. The company generates positive cash flow after capital investments, but with room for improvement.
Bioceres Crop Solutions Corp generates a -19.9% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 0/100. This is down from 2.1% the prior year.
Bioceres Crop Solutions Corp passes 2 of 9 financial strength tests. 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), neither operating efficiency signal passes.
For every $1 of reported earnings, Bioceres Crop Solutions Corp generates $-0.85 in operating cash flow ($49.9M OCF vs -$58.8M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.
Key Financial Metrics
Earnings & Revenue
Bioceres Crop Solutions Corp generated $335.1M in revenue in fiscal year 2025. This represents a decrease of 27.9% from the prior year.
Bioceres Crop Solutions Corp reported -$58.8M in net income in fiscal year 2025. This represents a decrease of 907.3% from the prior year.
Cash & Balance Sheet
Bioceres Crop Solutions Corp generated $44.3M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 38.6% from the prior year.
Bioceres Crop Solutions Corp held $32.7M in cash against $9.5M in long-term debt as of fiscal year 2025.
Bioceres Crop Solutions Corp had 63M shares outstanding in fiscal year 2025. This represents an increase of 0.6% from the prior year.
Margins & Returns
Bioceres Crop Solutions Corp's net profit margin was -17.6% in fiscal year 2025, showing the share of revenue converted to profit. This is down 19.1 percentage points from the prior year.
Bioceres Crop Solutions Corp's ROE was -19.9% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 22.0 percentage points from the prior year.
Capital Allocation
Bioceres Crop Solutions Corp invested $5.6M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 42.4% from the prior year.
BIOX Income Statement
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $73.8M-4.9% | $77.6M-5.9% | $82.4M+36.1% | $60.6M-38.7% | $98.8M+5.9% | $93.3M-24.8% | $124.0M+47.6% | $84.0M |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Income | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Interest Expense | -$8.0M+12.8% | -$9.1M | N/A | -$6.1M+5.0% | -$6.4M+10.2% | -$7.2M | N/A | -$7.2M |
| Income Tax | $3.1M+49.3% | $2.1M-64.8% | $5.9M+247.5% | -$4.0M-729.7% | $636K+150.2% | -$1.3M+68.6% | -$4.0M-321.4% | -$956K |
| Net Income | -$182.5M-2349.8% | -$7.4M+85.6% | -$51.7M-3147.0% | -$1.6M-362.9% | $605K+109.8% | -$6.2M-491.2% | -$1.0M-110.7% | $9.8M |
| EPS (Diluted) | $-0.08 | N/A | N/A | N/A | $0.10 | N/A | N/A | N/A |
BIOX Balance Sheet
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $560.4M-23.7% | $734.9M-3.8% | $763.6M-4.3% | $798.2M-4.4% | $835.2M+1.0% | $827.3M-3.0% | $852.5M+2.0% | $836.1M |
| Current Assets | $294.3M+3.9% | $283.2M-8.2% | $308.3M-8.8% | $338.2M-11.6% | $382.6M+1.5% | $377.1M-7.7% | $408.7M+0.4% | $407.2M |
| Cash & Equivalents | $11.1M-28.6% | $15.5M-52.6% | $32.7M-15.0% | $38.5M+31.8% | $29.2M-9.6% | $32.3M-27.4% | $44.5M+171.8% | $16.4M |
| Inventory | $64.8M-26.9% | $88.6M+1.1% | $87.6M-4.8% | $92.0M-9.6% | $101.8M-13.5% | $117.7M-6.6% | $125.9M-2.5% | $129.2M |
| Accounts Receivable | N/A | $158.4M-4.5% | $165.9M-11.5% | $187.5M-17.2% | $226.5M+15.7% | $195.8M-5.6% | $207.3M-1.8% | $211.2M |
| Goodwill | $36.1M-67.8% | $112.2M0.0% | $112.2M0.0% | $112.2M0.0% | $112.2M0.0% | $112.2M0.0% | $112.2M0.0% | $112.2M |
| Total Liabilities | $453.7M+1.6% | $446.5M-4.7% | $468.4M+3.4% | $453.2M-7.3% | $488.9M+1.6% | $481.2M-4.0% | $501.2M+2.8% | $487.6M |
| Current Liabilities | $328.6M+9.6% | $299.7M-11.3% | $338.0M+1.7% | $332.3M+15.1% | $288.8M-2.4% | $295.9M-10.2% | $329.3M-1.1% | $333.0M |
| Long-Term Debt | $8.1M-36.4% | $12.8M+34.0% | $9.5M-12.6% | $10.9M+0.4% | $10.8M-30.2% | $15.5M+90.4% | $8.2M-7.2% | $8.8M |
| Total Equity | $106.6M-63.0% | $288.3M-2.3% | $295.2M-14.4% | $345.0M-0.4% | $346.3M+0.1% | $346.0M-1.5% | $351.4M+0.8% | $348.5M |
| Retained Earnings | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
BIOX Cash Flow Statement
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $17.4M+20.9% | $14.4M-46.3% | $26.8M+14.7% | $23.3M+535.6% | -$5.4M-203.9% | $5.2M-77.8% | $23.3M+233.7% | -$17.4M |
| Capital Expenditures | -$12K-101.9% | $672K+56.1% | $431K-82.2% | $2.4M+59.2% | $1.5M+18.7% | $1.3M-36.6% | $2.0M+18.4% | $1.7M |
| Free Cash Flow | $17.4M+26.8% | $13.7M-48.0% | $26.3M+25.9% | $20.9M+404.3% | -$6.9M-277.3% | $3.9M-81.7% | $21.2M+211.2% | -$19.1M |
| Investing Cash Flow | -$2.8M-121.8% | -$1.3M-185.0% | $1.5M+159.4% | -$2.5M+53.5% | -$5.4M-2081.6% | $272K+192.1% | -$295K+78.5% | -$1.4M |
| Financing Cash Flow | -$18.0M+37.3% | -$28.7M-11.7% | -$25.7M-102.7% | -$12.7M-295.6% | $6.5M+134.5% | -$18.8M-453.3% | $5.3M-51.2% | $10.9M |
| Dividends Paid | N/A | N/A | $0 | $0 | N/A | N/A | $0-100.0% | $23K |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
BIOX Financial Ratios
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Margin | -247.2%-237.6pp | -9.6%+53.1pp | -62.7%-60.0pp | -2.6%-3.2pp | 0.6%+7.2pp | -6.6%-5.8pp | -0.9%-12.5pp | 11.6% |
| Return on Equity | -171.2%-168.6pp | -2.6%+14.9pp | -17.5%-17.0pp | -0.5%-0.6pp | 0.2%+2.0pp | -1.8%-1.5pp | -0.3%-3.1pp | 2.8% |
| Return on Assets | -32.6%-31.6pp | -1.0%+5.8pp | -6.8%-6.6pp | -0.2%-0.3pp | 0.1%+0.8pp | -0.8%-0.6pp | -0.1%-1.3pp | 1.2% |
| Current Ratio | 0.90-0.0 | 0.94+0.0 | 0.91-0.1 | 1.02-0.3 | 1.32+0.1 | 1.27+0.0 | 1.24+0.0 | 1.22 |
| Debt-to-Equity | 0.08+0.0 | 0.04+0.0 | 0.030.0 | 0.030.0 | 0.03-0.0 | 0.04+0.0 | 0.020.0 | 0.03 |
| FCF Margin | 23.5%+5.9pp | 17.7%-14.3pp | 31.9%-2.6pp | 34.5%+41.5pp | -7.0%-11.1pp | 4.2%-13.0pp | 17.1%+39.9pp | -22.7% |
Note: The current ratio is below 1.0 (0.91), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Frequently Asked Questions
What is Bioceres Crop Solutions Corp's annual revenue?
Bioceres Crop Solutions Corp (BIOX) reported $335.1M in total revenue for fiscal year 2025. This represents a -27.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Bioceres Crop Solutions Corp's revenue growing?
Bioceres Crop Solutions Corp (BIOX) revenue declined by 27.9% year-over-year, from $464.8M to $335.1M in fiscal year 2025.
Is Bioceres Crop Solutions Corp profitable?
No, Bioceres Crop Solutions Corp (BIOX) reported a net income of -$58.8M in fiscal year 2025, with a net profit margin of -17.6%.
How much debt does Bioceres Crop Solutions Corp have?
As of fiscal year 2025, Bioceres Crop Solutions Corp (BIOX) had $32.7M in cash and equivalents against $9.5M in long-term debt.
What is Bioceres Crop Solutions Corp's net profit margin?
Bioceres Crop Solutions Corp (BIOX) had a net profit margin of -17.6% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Bioceres Crop Solutions Corp's return on equity (ROE)?
Bioceres Crop Solutions Corp (BIOX) has a return on equity of -19.9% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Bioceres Crop Solutions Corp's free cash flow?
Bioceres Crop Solutions Corp (BIOX) generated $44.3M in free cash flow during fiscal year 2025. This represents a 38.6% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Bioceres Crop Solutions Corp's operating cash flow?
Bioceres Crop Solutions Corp (BIOX) generated $49.9M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Bioceres Crop Solutions Corp's total assets?
Bioceres Crop Solutions Corp (BIOX) had $763.6M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Bioceres Crop Solutions Corp's capital expenditures?
Bioceres Crop Solutions Corp (BIOX) invested $5.6M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is Bioceres Crop Solutions Corp's current ratio?
Bioceres Crop Solutions Corp (BIOX) had a current ratio of 0.91 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
What is Bioceres Crop Solutions Corp's debt-to-equity ratio?
Bioceres Crop Solutions Corp (BIOX) had a debt-to-equity ratio of 0.03 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Bioceres Crop Solutions Corp's return on assets (ROA)?
Bioceres Crop Solutions Corp (BIOX) had a return on assets of -7.7% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Bioceres Crop Solutions Corp's Piotroski F-Score?
Bioceres Crop Solutions Corp (BIOX) has a Piotroski F-Score of 2 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Bioceres Crop Solutions Corp's earnings high quality?
Bioceres Crop Solutions Corp (BIOX) has an earnings quality ratio of -0.85x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Bioceres Crop Solutions Corp?
Bioceres Crop Solutions Corp (BIOX) scores 34 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.